Study explores gene-expression screening for seabass deformity risk
Bottom line
A new study in Animals reports that researchers used gene expression markers and machine learning to classify European seabass larval batches by their later incidence of saddleback syndrome, a skeletal deformity that can affect larval quality, welfare, production efficiency, and market value. Saddleback syndrome in seabass has been documented as a hatchery-relevant abnormality that can appear at high frequency, with earlier work describing commercial hatchery incidences ranging from 12% to 94% and linking the condition to defects developing during larval ontogeny around flexion and metamorphosis. The new paper suggests transcriptomic screening could help identify high-risk batches before the deformity is fully apparent, potentially giving hatcheries an earlier decision point than visual culling alone. (vliz.be)
Why it matters: For veterinary and aquaculture professionals, the practical value is less about replacing morphology exams today and more about moving deformity surveillance upstream. In marine finfish hatcheries, skeletal abnormalities are a persistent welfare and economic problem, and European seabass remains one of Europe’s key cultured marine species. If gene-expression classifiers can be validated across facilities and production cycles, they could support earlier risk stratification, more targeted quality control, and better investigation of nutrition, environment, or husbandry factors contributing to abnormal development. Similar genomics-and-ML work in seabass has shown promise, but researchers in the field also note the challenge of making accurate predictions from high-dimensional data with relatively small sample sets. (pmc.ncbi.nlm.nih.gov)
What to watch: The next step is external validation: whether this classifier holds up in independent hatcheries, larger cohorts, and real-world workflows where cost, turnaround time, and interpretability will matter most. (pubmed.ncbi.nlm.nih.gov)
Key facts
- Study topic
- Gene expression markers and machine learning were used to classify European seabass larval batches by later saddleback syndrome incidence.
- Species
- European seabass (Dicentrarchus labrax)
- Condition
- Saddleback syndrome, a skeletal deformity
- Impact
- Can affect larval quality, welfare, production efficiency, and market value
- Earlier hatchery incidence
- 12% to 94% in commercial hatcheries
- Developmental timing
- Linked to defects developing during larval ontogeny around flexion and metamorphosis
- Potential use
- Transcriptomic screening could help identify high-risk batches before the deformity is fully apparent
- Main limitation
- Needs external validation in independent hatcheries and larger cohorts
Researchers reporting in Animals say they were able to classify European seabass larval batches according to later saddleback syndrome incidence using gene expression data combined with machine learning, pointing to a possible early-warning tool for one of marine hatcheries’ persistent quality and welfare problems. Based on the study abstract and the surrounding literature, the work is aimed at detecting batch-level risk before the deformity is fully visible, rather than waiting for conventional downstream phenotypic screening. (vliz.be)
That matters because saddleback syndrome isn’t a niche finding in seabass production. A foundational 2017 study in the Journal of Fish Diseases described the abnormality in hatchery-reared European seabass and reported unusually high frequencies, from 12% to 94%, during routine commercial quality control. That paper characterized saddleback syndrome as a dorsal-fin-related abnormality associated with additional defects involving the lateral line, anal fin, and pelvic fins, and placed its development during a broad ontogenetic window that included flexion and metamorphosis. Broader reviews of skeletal anomalies in reared marine fish have also framed these deformities as longstanding production and welfare concerns, often tied to complex interactions among nutrition, rearing conditions, and developmental timing. (vliz.be)
The new study appears to build on that biological background by asking a more operational question: can molecular signals identify which larval batches are likely to produce more affected fish later on? That’s a meaningful shift for hatchery management. Instead of using gene expression only to explain pathogenesis after the fact, the authors are positioning transcriptomic markers as a classification tool. That approach is consistent with a wider trend in aquaculture genomics, where machine learning is increasingly being tested for phenotype prediction in European seabass, including disease resistance and other production-relevant traits. Recent work on viral nervous necrosis resistance, for example, found that machine learning can be useful in seabass even under the difficult conditions of high-dimensional data and limited sample sizes, though performance depends heavily on scenario design and feature selection. (pubmed.ncbi.nlm.nih.gov)
There’s also a plausible biological rationale for looking at gene expression around deformity risk. Other seabass abnormality studies have linked altered expression of bone and tissue-remodeling genes to fin-related syndromes, including ray-resorption syndrome, while older larval transcriptomic work has shown that developmental-stage gene expression in seabass changes substantially across early ontogeny. Taken together, that literature supports the idea that molecular signatures may capture developmental divergence before external morphology alone tells the full story. Still, based on related seabass ML studies, any strong practical claims will depend on whether the model was trained on enough batches, whether it was tested on independent data, and whether the selected markers remain stable across hatchery environments. (pubmed.ncbi.nlm.nih.gov)
I didn’t find a separate press release or public industry statement tied to this paper, and I also didn’t find independent expert commentary specifically on this study. What I did find is a broader research and industry push toward earlier, more automated detection of seabass abnormalities, including AI-based visual screening tools for fin, operculum, and skin deformities under farming conditions. That suggests the field is moving on two parallel tracks: molecular prediction upstream, and automated phenotype detection downstream. The new paper fits neatly into that broader effort to make hatchery quality control more predictive and less reactive. (sciencedirect.com)
Why it matters: For veterinary professionals working in aquaculture, the significance is practical. Skeletal deformities affect welfare, survival, throughput, and the consistency of fish supplied to grow-out systems. A batch-level molecular classifier, if validated, could help teams identify risk earlier, refine sampling plans, and investigate whether broodstock, live feed, micronutrition, water quality, or other larval-stage variables are contributing to abnormal outcomes. It could also support more evidence-based conversations with hatchery managers about when to intensify monitoring or intervene. But the bar for adoption will be high: the assay has to be reproducible, fast enough to inform decisions, affordable at scale, and interpretable enough that hatcheries trust what it’s flagging. (onlinelibrary.wiley.com)
What to watch: The key questions now are whether the model can be reproduced outside the original dataset, whether the marker panel can be narrowed to a practical test, and whether future studies tie the molecular signal back to modifiable risk factors. If those steps follow, this line of work could move from an interesting research result to a usable hatchery surveillance tool. (pubmed.ncbi.nlm.nih.gov)